TEE
IART icon

Tibra Equities Europe’s Integra LifeSciences IART Stock Holding History

Tibra Equities Europe’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,300
Closed -$685K – 345
2019
Q1 		$685K Buy
+12,300
New +$626K 0.07% 224
2018
Q3 		– Sell
-62,895
Closed -$4.05M – 222
2018
Q2 		$4.05M Buy
+62,895
New +$3.89M 0.61% 46

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tibra Equities Europe's IART Position: Q2 2019 in Review

Tibra Equities Europe sold out of Integra LifeSciences (IART) in Q2 2019, closing a stake of 12,300 shares — an estimated $685K sold.

Tibra Equities Europe first reported a position in IART in Q2 2018 and held it in 2 quarters. The position peaked at $4.05M in Q2 2018. 262 funds tracked by Wall St. Rank hold IART as of Q2 2019.

  • Tibra Equities Europe reported no remaining Integra LifeSciences position as of Q2 2019 after selling out during the quarter.
  • Tibra Equities Europe sold 12,300 Integra LifeSciences shares in Q2 2019, an estimated $685K.
  • Tibra Equities Europe first reported a position in Integra LifeSciences in Q2 2018 and held it in 2 quarters.
  • Tibra Equities Europe's Integra LifeSciences position peaked at $4.05M in Q2 2018.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2019.

Based on Tibra Equities Europe's 13F filing for Q2 2019, filed 1 Aug 2019.